| Active enthesitis in PsO (n=57) | Active enthesitis in PsOAr (n=61) | |||||
| Age, mean (±SD) | 57.2 (±11.78) | 49.26 (±17.26) | 0.2 | 54.18 (±6.93) | 49.07 (±13.6) | 0.16 |
| Female, n (%) | 2 (20%) | 26 (55.32%) | 0.079 | 10 (58.82%) | 24 (54.55%) | 1 |
| Smoking, n (%) | 1 (10%) | 16 (34.04%) | 0.153 | 1 (5.88%) | 4 (9.09%) | 0.06 |
| BMI, mean (±SD) | 26.39 (±3.34) | 25.23 (±4.07) | 0.309 | 29.95 (±3.73) | 25.9 (±5.2) | 0.58 |
| Alcohol, n (%) (daily intake) | 0 | 0 | 0.955 | 0 | 0 | 0.87 |
| Diabetes mellitus, n (%) | 0 | 3 (6.38%) | 1 | 2 (11.76%) | 3 (6.82%) | 0.61 |
| Hypertension, n (%) | 2 (20%) | 9 (19.15%) | 1 | 4 (23.53%) | 15 (34.09%) | 0.54 |
| Metabolic syndrome, n (%) | 0 | 4 (8.51%) | 1 | 4 (23.53%) | 7 (15.91%) | 0.48 |
| HAQ, mean (±SD) | 0.35 (±0.94) | 0.17 (±0.32) | 0.684 | 0.34 (±0.3) | 0.37 (±0.42) | 0.87 |
| VAS, mean (±SD) | 2.56 (±2.52) | 1.73 (±2.37) | 0.254 | 4.35 (±2.17) | 3.56 (±2.4) | 0.18 |
| PASI, mean (±SD) | 4.52 (±2.58) | 3.65 (±3.41) | 0.153 | 3.86 (±2.69) | 4.53 (±6.46) | 0.59 |
| NAPSI, mean (±SD) | 8 (±7.05) | 9.31 (±8.86) | 0.903 | 13.44 (±8.43) | 5.29 (±5.94) | 0.03 |
BMI, body mass index; HAQ, Health Assessment Questionnaire; NAPSI, Nail Psoriasis Severity Index; PASI, Psoriasis Area and Severity Index; PsO, psoriasis alone; PsOAr, psoriatic patients with arthralgia; VAS, Visual Analogue Scale.